Skip to main content

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 469))

Abstract

In the peritoneal plasmacytomagenesis (PCTG) model system, plasmacytomas (PCTs) are induced when different kinds of metabolically inert substances (paraffin oils, silicones, polycarbonate solid discs) are introduced into the peritoneal cavities of genetically susceptible BALB/cAn mice. The PCTs develop morphologically in the chronic inflammatory tissue that forms in peritoneal connective tissues in response to these agents. The most extensively studied agent is pristane (2,6,10,14-tetramethylpentadecane)1,2. This induction system has been useful in identifying steps and biological determinants in plasma cell neoplasia. Important features of pristane PCTG in the mouse are: 1) the remarkable dependence on the BALB/cAn genotype and, specifically, the chromosome-4 PCT susceptibility genes Pctr 1 and Pctr23,4; 2) the consistent (>95%) appearance of chromosomal translocations t(6;15)or t(12;15) that are associated with rearrangement of Immunoglobulin (Ig) genes and c-myc and result in the deregulation of c-myc transcription5,6; 3) the influence of natural antigenic stimulation [Specific Pathogen Free BALB/cAnPt mice that have a very restricted exposure to environmental antigens are resistant to PCT induction by pristane7]; 4) the dependence upon the special vascular and immunological properties of the peritoneal space8; and 5) the dependence for growth and progression on the reactive chronic inflammatory microenvironments and cytokines, e.g., IL-69–11.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Refferences

  1. Anderson, P. N. & Potter, M. Nature222, 994–995 (1969).

    Article  PubMed  CAS  Google Scholar 

  2. Porter, M. & Wax, J. S. J. Natl. Cancer Inst.71, 391–395 (1983).

    Google Scholar 

  3. Mock, B. A., Krall, M. M. & Dosik, J. K. Proc. Natl. Acad. Sci. USA90, 9499–9503 (1993).

    Article  PubMed  CAS  Google Scholar 

  4. Potter, M., Mushinski, E. B., Wax, J. S., Hartley, J. & Mock, B. A. Cancer Res.54, 969–975 (1994).

    PubMed  CAS  Google Scholar 

  5. Mushinski, J. F. in Cellular Oncogene Activation(ed Klein, G.) 181–222 ( Marcel Dekker, Inc. New York, 1988).

    Google Scholar 

  6. Cory, S.Adv. Cancer Res.47, 189–211 (1986).

    Article  CAS  Google Scholar 

  7. Byrd, L. G., McDonald, A. H., Gold, L. G. & Potter, M. J. Immunol.147, 3632–3637 (1991).

    PubMed  CAS  Google Scholar 

  8. Anderson, A. O., Wax, J. S. & Potter, M. Curr. Top. Microbiol. Immunol.122, 242–253 (1985).

    Article  PubMed  CAS  Google Scholar 

  9. Hinson, R. M., Williams, J. A. & Shacter, E. Proc. Natl Acad. Sci. USA93, 4885–4890 (1996).

    Article  PubMed  CAS  Google Scholar 

  10. Nordan, R. P. & Potter, M. Science233, 566–569 (1986).

    Article  PubMed  CAS  Google Scholar 

  11. Lattanzio, G, Libert, C, Aquilina, M., et al. Am.J. Pathol.151, 689–696 (1997).

    PubMed  CAS  Google Scholar 

  12. Muller, J. R, Jones, G. M., Janz, S. & Potter, M. Blood 89, 291–296 (1997).

    PubMed  CAS  Google Scholar 

  13. Potter, M., Wax, J. S., Anderson, A. O. & Nordan, R. P. J. Exp. Med.161, 996–1012 (1985).

    Article  PubMed  CAS  Google Scholar 

  14. Potter, M., Wax, J. & Jones, G. M. Blood90, 260–269 (1997).

    PubMed  CAS  Google Scholar 

  15. Merwin, R. M. & Redmon, L. W. J. Natl. Cancer Inst.31, 990–1007 (1963).

    Google Scholar 

  16. Abramson, S. B. & Weissmann, G.Arthritis Rheum.32, 1–9 (1989).

    Article  CAS  Google Scholar 

  17. Levy, G. N. FASEB J. 11, 234–247 (1997).

    PubMed  CAS  Google Scholar 

  18. Loll, P. J. in New targets in inflammation. Inhibitors of COX-2 or adhesion molecules(eds Bazan, N., Botting, J. & Vane, J.) 13–21 (Kluwer Academic Publishers, Dordrecht, 199

    Google Scholar 

  19. Picot, D., Loll, P. J. & Garavito, R. M. Nature367, 243–249 (1994).

    Article  PubMed  CAS  Google Scholar 

  20. Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. & Kliewer, S. A. J. Biol. Chem.272, 3406–3410 (1997).

    Article  PubMed  CAS  Google Scholar 

  21. Arkins, S., Rebeiz, N., Biragyn, A., Reese, D. L. & Kelley, K. W. Endocrinology133, 2334–2343 (1993).

    Article  PubMed  CAS  Google Scholar 

  22. McDonald, A. H. & Degrassi, A. Cell.Immunol146, 157–170 (1993).

    Article  PubMed  CAS  Google Scholar 

  23. Shacter, E., Beecham, E. J., Covey, J. M., Kohn, K. W. & Potter, M. Carcinogenesis9, 2297–2304 (1988).

    Article  PubMed  CAS  Google Scholar 

  24. Schraufstatter, I., Hyslop, P. A., Jackson, J. H. & Cochrane, C. G. J.Clin.Invest.82, 1040–1050 (1988).

    Article  PubMed  CAS  Google Scholar 

  25. Umeki, S. BiochemPharmacol.40, 559–564 (1990).

    CAS  Google Scholar 

  26. Smith, R. J. & Iden, S. S. BiochemPharmacol29, 2389–2395 (1980).

    CAS  Google Scholar 

  27. Oyanagui, Y. Biochem.Pharmacol.25, 1473–1480 (1976).

    Article  PubMed  CAS  Google Scholar 

  28. Aruoma, O. I. & Halliwell, B.Xenobiotica 18, 459–470 (1988).

    Article  CAS  Google Scholar 

  29. Marnett, L. J. Environ. Health Perspect.88, 5–12 (1990).

    Article  PubMed  CAS  Google Scholar 

  30. Schreck, R. & Baeuerle, P. A. Trends Cell Biol.1, 39–42 (1991).

    Article  PubMed  CAS  Google Scholar 

  31. Di Gianni, P., Minnucci, F. S., Alves Rosa, M. F., Vulcano, M. & Isturiz, M. A. ScandJ. Immunol43, 413–420 (1996).

    Article  Google Scholar 

  32. Marnett, L. J. Cancer Res.52, 5575–5589 (1992).

    PubMed  CAS  Google Scholar 

  33. Hanif, R., Pittas, A., Feng, Y., et al. BiochemPharmacol.52, 237–245 (1996).

    CAS  Google Scholar 

  34. Chan, T. A., Morin, P. J., Vogelstein, B. & Kinzler, K. W. Proc. Natl. Acad. Sci. U. S. A.95, 681–686 (1998).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Potter, M. (1999). Indomethacin Inhibition of Pristane Plasmacytomagenesis in Genetically Susceptible Inbred Mice. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4793-8_23

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7171-7

  • Online ISBN: 978-1-4615-4793-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics